A novel cohorting and isolation strategy for suspected COVID-19 cases during a pandemic

J Hosp Infect. 2020 Aug;105(4):632-637. doi: 10.1016/j.jhin.2020.05.035. Epub 2020 May 30.

Abstract

Background: The COVID-19 pandemic presents a significant infection prevention and control challenge. The admission of large numbers of patients with suspected COVID-19 disease risks overwhelming the capacity to protect other patients from exposure. The delay between clinical suspicion and confirmatory testing adds to the complexity of the problem.

Methods: We implemented a triage tool aimed at minimizing hospital-acquired COVID-19 particularly in patients at risk of severe disease. Patients were allocated to triage categories defined by likelihood of COVID-19 and risk of a poor outcome. Category A (low-likelihood; high-risk), B (high-likelihood; high-risk), C (high-likelihood; low-risk) and D (low-likelihood; low-risk). This determined the order of priority for isolation in single-occupancy rooms with Category A the highest. Patients in other groups were cohorted when isolation capacity was limited with additional interventions to reduce transmission.

Results: Ninety-three patients were evaluated with 79 (85%) receiving a COVID-19 diagnosis during their admission. Of those without a COVID-19 diagnosis: 10 were initially triaged to Category A; 0 to B; 1 to C and 4 to D. All high-risk patients requiring isolation were, therefore, admitted to single-occupancy rooms and protected from exposure. Twenty-eight (30%) suspected COVID-19 patients were evaluated to be low risk (groups C and D) and eligible for cohorting. No symptomatic hospital-acquired infections were detected in the cohorted patients.

Discussion: Application of a clinical triage tool to guide isolation and cohorting decisions may reduce the risk of hospital-acquired transmission of COVID-19 especially to individuals at the greatest of risk of severe disease.

Keywords: COVID-19; Cohorting; Infection prevention and control; Pandemic; Risk stratification; Triage.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Betacoronavirus / isolation & purification*
  • COVID-19
  • Cohort Studies
  • Coronavirus Infections / diagnosis*
  • Cross Infection / prevention & control*
  • Female
  • Guidelines as Topic*
  • Humans
  • London
  • Male
  • Middle Aged
  • Pandemics / prevention & control*
  • Pneumonia, Viral / diagnosis*
  • SARS-CoV-2
  • Triage / standards*
  • Triage / statistics & numerical data*